Abbott’s paravalvular leak treatment secures FDA approval
Abbott’s Amplatzer Paraclose Occluder has secured US Food and Drug Administration (FDA) approval, making it the first transcatheter device approved…
News
Baxter’s shares fall as Q3 probability dips despite revenue growth
FDA expands approval of Instylla’s Embrace HES for arterial bleeds
StimCardio secures $30m in Series A round for wearable AF therapy
BMA laments low NHS investment in UK’s Autumn Budget
GE HealthCare raises 2026 outlook after positive Q3
SetPoint treats first patient with neuroimmune modulation system
Empatica introduces WellPD Parkinson’s wearable device
